Tulane Cancer Center Clinical Research Protocols January 2006 Tulane Office of Clinical Research (985) 624-9683

Brain Breast Gastro-intestinal Genito-urinary Gynecological Head & Neck Leukemia

Liver Lung Lymphoma Melanoma Multiple Myeloma Neuroblastoma Soft Tissues Sarcoma

General AIDS-related Bone Marrow Transplant Pediatric

Hematopoietic Failure and Genetic Disease Transplant Studies

---

See also: Tulane's ACCTION regional clinical trials network.

AIDS-Related Cancers
None currently open to accrual

---

Brain
None currently open to accrual

---

Breast
None currently open to accrual

---

Gastro-intestinal
None currently open to accrual

---

Genito-urinary
None currently open to accrual

---

Gynecologic
None currently open to accrual

---

Head and Neck
None currently open to accrual

---

Leukemia
General

SWOG   #   9007 IRB 9/12/91

Companion to any SWOG LEUKEMIA study: Cytogenetics (marrow)

Acute

SWOG #   S0301 IRB 03/11/2004	A Phase II study of induction with Daunorubicin, Cytarabine, and Cyclosporine all by continuous IV infusion for previously untreated non-M3 acute myeloid leuemia (AML) in patients age 56 or older. Temporary closure as of March 2004.
Tulane BMT   #   98-1 IRB 11/10/98	TRANSPLANT: Bone marrow transplant for high-risk LEUKEMIAS with busulfan, CTX, and Etoposide * Tulane investigator-initiated study

Chronic

BMT   #   2000-01 IRB 1/25/00

CML in the first chronic phase. Allogeneic BMT for chronic myelogenous leukemia using primed bone marrow stem cells. Tulane investigator-initiated study.

---

Liver
None currently open to accrual

---

Lung
Non-small-cell

SWOG   #   E5597 IRB 6/14/01

(Post-op, Stage IA, pT1N0 or Stage IB, pT1N0) "Phase III Chemoprevention Trial of Selenium Supplementation in Persons with Resected Stage I Non-Small-Cell Lung Cancer"

---

Lymphoma
Hodgkins'

SWOG   #   E2496 IRB 12/31/99

Randomized phase III trial of ABVD versus Stanford v +/- radiation therapy in locally extensive and advanced stage Hodgkin's disease with 0-2 risk factors.

Non-Hodgkins'

Tulane BMT   #   99-2 IRB 2/24/00

Autologous transplantation for non-Hodgkin's lymphoma. The role of in vivo purging with monoclonal antibody.

AIDS-related Non-Hodgkins'

SWOG   #   8947 IRB 5/10/90	Companion to SWOG S9704: Central serum repository (mandatory)
SWOG   #   9245 IRB 05/13/93	Companion to SWOG S9704: Central lymphoma repository tissue procurement protocol for relapsed or recurrent disease (optional)

---

Melanoma
None currently open to accrual

---

Multiple Myeloma

Tulane BMT   #   99-1 IRB 08/02/99	MULTIPLE MYELOMA: Immuno-transplantation for lymphoid malignancy using allogeneic blood stem cells.
Tulane   #   HSO1.02 IRB 3/12/02	MULTIPLE MYELOMA: Autologous peripheral stem cell transplantation for multiple myeloma: Safety and efficacy of the use of Rituxan for in vivo purging prior to high-dose chemotherapy and peripheral stem cell transplantation in the treatment of multiple myeloma. * Tulane investigator-initiated.

---

Neuroblastoma
None currently open to accrual

---

Soft Tissues Sarcoma
None currently open to accrual

---

Hematopoietic Failure and Genetic Disease Transplant Studies

Tulane BMT   #   2001-03 IRB 7/17/2001

Phase II trial of CD34 selected peripheral blood progenitor cells with immunoablation in the treatment of severe autoimmune disease

---

General protocols
None currently open to accrual

NOTICE TO ACCTION NETWORK RESEARCHERS: NIH policy requires all individuals involved in research with humans that is funded by the NIH to receive education in the protection of human research participants. To comply with this requirement, the NSABP is requiring that all NSABP investigators (any physician responsible for administering therapy and/or for consenting patients on NSABP treatment protocols) must complete training in the protection of human research participants. Acceptable forms of training include the NIH Web site training program at http://ohsr.od.nih.gov/cbt. This is also available in the Member's Area of the NSABP Web site at http://www.nsabp.pitt.edu and on the Tulane Web site at http://www.som.tulane.edu/irb/program.

Return to the top of this page.
Return to the Tulane Cancer Center homepage.
Calendars Clinical Trials Faculty Links Location News
Search Site index

---

This page is http://www.som.tulane.edu/cancer/protocols/default.html

---

Tulane Cancer Center, Box HC-62
1430 Tulane Avenue
New Orleans, Louisiana 70112-2699

Tulane Office of Clinical Research
(504) 988-6121, (800) 588-5800